Cerebral Ischemia Related to Isotretinoin; Venlafaxine-Induced Alopecia; Cognitive Dysfunction with Tolterodine; Retinal Artery Occlusion After Injection of Long-Acting Risperidone; Olanzapine-Induced Chylomicronemia Presenting as Pancreatitis; Metabolic Effects of the Atypical Antipsychotics – An Editorial; Another Drug-Induced Pancreatitis – This One Caused by a Tyrosine Kinase Inhibitor; Suicide Attempts Related to Antidepressant Medications
November 2007
in “
Hospital pharmacy
”
TLDR The conclusion is that healthcare professionals should report adverse drug reactions to improve medication safety and patient care.
The document discussed various adverse drug reactions (ADRs) associated with specific medications, including cerebral ischemia linked to isotretinoin, venlafaxine-induced alopecia, cognitive dysfunction with tolterodine, retinal artery occlusion following long-acting risperidone injection, olanzapine-induced chylomicronemia presenting as pancreatitis, and drug-induced pancreatitis caused by a tyrosine kinase inhibitor. It aimed to raise awareness, suggest prevention methods, and encourage reporting of ADRs to the FDA's MEDWATCH program. The feature was provided by the Institute for Safe Medication Practices in collaboration with the FDA and Temple University School of Pharmacy.
